LI
NVAX icon

LRI Investments’s Novavax NVAX Stock Holding History

LRI Investments’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$867 – 1390
2025
Q3 		$867 Hold
100
– – ﹤0.01% 1266
2025
Q2 		$630 Hold
100
– – ﹤0.01% 1230
2025
Q1 		$641 Hold
100
– – ﹤0.01% 1172
2024
Q4 		$804 Hold
100
– – ﹤0.01% 1119
2024
Q3 		$722 Hold
100
– – ﹤0.01% 1115
2024
Q2 		$1.27K Hold
100
– – ﹤0.01% 1087
2024
Q1 		$478 Buy
+100
New +$464 ﹤0.01% 823

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LRI Investments's NVAX Position: Q4 2025 in Review

LRI Investments sold out of Novavax (NVAX) in Q4 2025, closing a stake of 100 shares — an estimated $867 sold.

LRI Investments first reported a position in NVAX in Q1 2024 and held it in 7 quarters. The position peaked at $1.27K in Q2 2024. 235 funds tracked by Wall St. Rank hold NVAX as of Q4 2025.

  • LRI Investments reported no remaining Novavax position as of Q4 2025 after selling out during the quarter.
  • LRI Investments sold 100 Novavax shares in Q4 2025, an estimated $867.
  • LRI Investments first reported a position in Novavax in Q1 2024 and held it in 7 quarters.
  • LRI Investments's Novavax position peaked at $1.27K in Q2 2024.
  • 235 funds tracked by Wall St. Rank held Novavax as of Q4 2025.

Based on LRI Investments's 13F filing for Q4 2025, filed 4 Feb 2026.